ImmunoGen
ImmunoGen is a US biotechnology business founded in 1981 that developed antibody-drug conjugates for cancer treatment, including ELAHERE. It was headquartered in Waltham, Massachusetts, before AbbVie acquired the company in February 2024. Its scientific roots include antibody research at Dana-Farber Cancer Institute involving Baruj Benacerraf. ImmunoGen's therapies and research programs became part of AbbVie's oncology portfolio.
Key facts
| Legal Name | ImmunoGen, Inc. |
|---|---|
| Company Operating Status | Acquired |
| Wellfound ID | immunogen |
| Wikidata ID | Q15964806 |
Contact details
Email and phone for ImmunoGen are available to signed-in members of CliffBio.
Sign in to view